Literature DB >> 11315098

Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades.

S S Lakka1, S L Jasti, A P Kyritsis, W K Yung, F Ali-Osman, G L Nicolson, J S Rao.   

Abstract

Our previous studies have shown that MMP-9 levels are significantly elevated during the progression of human gliomas. In the current study, we examined the role of JNK- and ERK-dependent signaling modules in the regulation of MMP-9 production and the invasive behavior of the human glioblastoma cell line SNB19, in which JNK/ERK1 is constitutively activated. SNB19 cells that were transfected with dominant-negative JNK, MEKK, and ERK1 expression vectors showed reduced MMP-9 promoter activity. In addition, conditioned medium collected from SNB19 cells transfected with these expression vectors showed diminished MMP-9 activity in the presence of phorbol myristate acetate, as determined by gelatin zymography. The cotransfection of SNB19 cells with kinase-deficient c-raf also diminished MMP-9 promoter activity. Further, in the presence of a specific inhibitor of MEKK (PD098059), the Matrigel invasion assay showed the invasiveness of dominant-negative SNB19 cells transfected with dominant-negative JNK1 or ERK1 to be remarkably reduced. In conclusion, our studies showed for the first time that MMP-9 production and the invasive behavior of SNB 19 cells are regulated by JNK- and ERK-dependent signaling modules and that interfering with either of the pathways reduces invasiveness.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11315098     DOI: 10.1023/a:1006724826083

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  47 in total

1.  Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase.

Authors:  J T Bruder; G Heidecker; U R Rapp
Journal:  Genes Dev       Date:  1992-04       Impact factor: 11.361

2.  Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.

Authors:  M Verheij; R Bose; X H Lin; B Yao; W D Jarvis; S Grant; M J Birrer; E Szabo; L I Zon; J M Kyriakis; A Haimovitz-Friedman; Z Fuks; R N Kolesnick
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

3.  JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain.

Authors:  B Dérijard; M Hibi; I H Wu; T Barrett; B Su; T Deng; M Karin; R J Davis
Journal:  Cell       Date:  1994-03-25       Impact factor: 41.582

4.  Laminin: a potential inhibitor of rat glioma cell invasion in vitro.

Authors:  A Reith; R Bjerkvig; G J Rucklidge
Journal:  Anticancer Res       Date:  1994 May-Jun       Impact factor: 2.480

5.  Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors.

Authors:  J S Rao; P A Steck; S Mohanam; W G Stetler-Stevenson; L A Liotta; R Sawaya
Journal:  Cancer Res       Date:  1993-05-15       Impact factor: 12.701

6.  Cytokine-mediated regulation of rat ovarian function: interleukin-1 stimulates the accumulation of a 92-kilodalton gelatinase.

Authors:  A Hurwitz; M Dushnik; H Solomon; A Ben-Chetrit; Z Finci-Yeheskel; A Milwidsky; M Mayer; E Y Adashi; S Yagel
Journal:  Endocrinology       Date:  1993-06       Impact factor: 4.736

7.  Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells.

Authors:  H Sato; M Seiki
Journal:  Oncogene       Date:  1993-02       Impact factor: 9.867

8.  Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences.

Authors:  R Gum; E Lengyel; J Juarez; J H Chen; H Sato; M Seiki; D Boyd
Journal:  J Biol Chem       Date:  1996-05-03       Impact factor: 5.157

9.  The influence of sequential, in vitro passage on secretion of matrix metalloproteinases by human brain tumour cells.

Authors:  M Rossi; H K Rooprai; S L Maidment; G J Rucklidge; G J Pilkington
Journal:  Anticancer Res       Date:  1996 Jan-Feb       Impact factor: 2.480

10.  Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas.

Authors:  P A Forsyth; H Wong; T D Laing; N B Rewcastle; D G Morris; H Muzik; K J Leco; R N Johnston; P M Brasher; G Sutherland; D R Edwards
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

View more
  16 in total

1.  Downregulation of uPA, uPAR and MMP-9 using small, interfering, hairpin RNA (siRNA) inhibits glioma cell invasion, angiogenesis and tumor growth.

Authors:  Christopher S Gondi; Sajani S Lakka; Dzung H Dinh; William C Olivero; Meena Gujrati; Jasti S Rao
Journal:  Neuron Glia Biol       Date:  2004-05

2.  Perturbation of hyaluronan interactions inhibits malignant properties of glioma cells.

Authors:  Jeanine A Ward; Lei Huang; Huiming Guo; Shibnath Ghatak; Bryan P Toole
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

3.  PAK1 regulates breast cancer cell invasion through secretion of matrix metalloproteinases in response to prolactin and three-dimensional collagen IV.

Authors:  Leah Rider; Peter Oladimeji; Maria Diakonova
Journal:  Mol Endocrinol       Date:  2013-06-06

Review 4.  New insights into the regulation of the actin cytoskeleton by tropomyosin.

Authors:  C-L Albert Wang; Lynne M Coluccio
Journal:  Int Rev Cell Mol Biol       Date:  2010       Impact factor: 6.813

5.  Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma.

Authors:  Ben Davidson; Vered Givant-Horwitz; Philip Lazarovici; Björn Risberg; Jahn M Nesland; Claes G Trope; Erik Schaefer; Reuven Reich
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Characterization of ovarian cancer ascites on cell invasion, proliferation, spheroid formation, and gene expression in an in vitro model of epithelial ovarian cancer.

Authors:  Marie-Line Puiffe; Cécile Le Page; Abdelali Filali-Mouhim; Magdalena Zietarska; Véronique Ouellet; Patricia N Tonin; Mario Chevrette; Diane M Provencher; Anne-Marie Mes-Masson
Journal:  Neoplasia       Date:  2007-10       Impact factor: 5.715

7.  Matrix metalloproteinase-9 inhibition down-regulates radiation-induced nuclear factor-kappa B activity leading to apoptosis in breast tumors.

Authors:  Sateesh Kunigal; Sajani S Lakka; Pushpa Joseph; Norman Estes; Jasti S Rao
Journal:  Clin Cancer Res       Date:  2008-06-01       Impact factor: 12.531

8.  Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells.

Authors:  Kang Jin Jeong; Soon Young Park; Ji Hye Seo; Kyung Bok Lee; Wahn Soo Choi; Jeung Whan Han; Jae Ku Kang; Chang Gyo Park; Yong Kee Kim; Hoi Young Lee
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

Review 9.  Turning back the clock: regression of abdominal aortic aneurysms via pharmacotherapy.

Authors:  Hiroki Aoki; Koichi Yoshimura; Masunori Matsuzaki
Journal:  J Mol Med (Berl)       Date:  2007-05-24       Impact factor: 4.599

10.  A complete compilation of matrix metalloproteinase expression in human malignant gliomas.

Authors:  Carsten Hagemann; Jelena Anacker; Ralf-Ingo Ernestus; Giles H Vince
Journal:  World J Clin Oncol       Date:  2012-05-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.